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Bacillus subtilis is a rod shaped, aerobic, endospore forming gram-positive 
bacterium. B. subtilis is used as a model organism to study cell differentiation 
during sporulation in prokaryotes. When there is inadequate supply of carbon 
resources, B. subtilis undergoes a process of sporulation.The mother cell metabolic 
gene (mmg) operon is expressed at early stages of sporulation. It has six open 
reading frames mmgABCDE and yqiQ. The products of these genes mmg A, B, C, 
D, E and yqiQ in mmg operon share sequence homology with enzymes involved in 
fatty acid metabolism and methyl citric acid cycle. The genes mmgABCD were 
successfully cloned, over expressed and purified. The fatty acid degradation 
enzymes exist, as a complex in E.coli and our hypothesis is that the fatty acid 
degradation proteins may function as a complex as well. We tested this hypothesis 
by cloning and coexpressing all four mmg ABCD in a single strain of E.coli. This 
was accomplished by cloning mmgA with a His-tag for Ni-NTA affinity 
chromatography. If the four proteins formed a complex, the remaining mmgBCD 
would co-purify with the His-tagged mmgA. We observed a ~26 kDa protein 
coeluting with mmgA (which may be mmgB) and also 40-50 kDa protein.(mmgC 
- 40710 Da and mmgD- 41946 Da)
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CHAPTER I 
 
INTRODUCTION 
I.A Sporulation in Bacillus subtilis1 
Bacillus subtilis is an aerobic, gram-positive, endospore forming, rod 
shaped bacterium. It secretes enzymes that are of commercial importance in 
various industries. Hence this organism is extensively studied. The genome of 
this bacterium has around 4000 protein coding sequences, which include 87% of 
the genome sequence.  
Because of its ability to use different carbohydrates, the glycolytic pathway 
along with the TCA cycle is utilized in this organism. It also can grow in 
anaerobic conditions using nitrogen as the electron acceptor. Under dense 
population conditions or during carbon and nitrogen starvation, B. subtilis 
undergoes a developmental pathway where it produces spores. Spores are 
different from vegetative cells as they are more resistant to high temperatures and 
organic solvents. This is the only process that occurs in the stationary phase of the 
B.subtilis culture growth. At the end of exponential phase and the beginning of 
stationary phase morphological changes take place which leads to the formation 
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of dormant endospore and this transition takes place by the involvement of the 
enzymes in the Kreb’s cycle.2 
Sporulation is a complex process that involves the sequential activation 
and regulation of the different σ subunits in RNA polymerase (RNAP) resulting 
in the formation of a larger mother cell and a smaller forespore. The RNAP is a 
large molecule. The core enzyme has 6 different subunits, α2β2σω. The core of 
RNA polymerase is itself capable of synthesizing RNA, but it recognizes the 
specific promoter regions with the binding of the σ subunit.3 Sequential activation 
of the different σ-subunits of RNA polymerase occurs during sporulation. Each σ 
factor is responsible for the gene recognition by RNA polymerase. Morphological 
changes occur in sporulation due to the transcription of particular genes as shown 
in figure 3. 
Spo0A, which is a key regulatory protein, has to be phosphorylated by a 
phosphorelay cascade for spore formation. Phosphorelay is a multistage process, 
which involves the movement of phosphoryl groups of histidine kinases in the 
bacterial signal transduction. The decision to sporulate is taken when there is a 
signal due to nutrient depletion, cell density and DNA damage. These signals are 
used to induce phosphorylation in Spo0A. There are around 3 histidine kinases 
involved in the phosphorylation of Spo0A. These kinases transfer the phosphate 
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group to relay protein Spo0F, from there to Spo0B and then finally to Spo0A. 
Phosphorylation of the Asp residue in the N-terminal domain activates the 
regulator protein Spo0A. Accumulation of this Spo0A ~P is needed to activate 
the transcription of genes that help for the sporulation. This Spo0A ~P activates 
the transcription by binding to the promoters of these genes and operons, which 
acts in conjunction with the σA factor of RNA polymerase in spoIIE and spoIIG 
and σH in spoIIA.4 
 
 
 
 
Figure 1: Phosphorylation and formation of Spo0A~P 
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I.B Stages involved in the Sporulation: 
 
Figure 2: Stages involved in Spore Formation6 
 
 
 
The vegetative cells before entering the sporulation stage are said to be in 
the stage 0.7 DNA replication, axial filament and polar FtsZ ring formation occur 
in this stage.  
Many genes are involved in the sporulation process and are named “spo” 
genes. Activation of the Spo0A is needed for the initiation of the sporulation. 
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Septation of the polar FtsZ rings occurs in stage II. A larger mother cell and a 
small forespore are formed. σA is present in the growing cells in this stage. σH 
directs the transcription of genes whose products are needed in the septum 
formation and in the chromosomal division where one copy of it goes to the 
mother cell and other to the forespore. These σA and σH transcribe operons that 
have σE and σF respectively. These are dormant until the polar septum is formed.  
σF becomes active in the forespore and σE in the mother cell.  After the septum is 
formed, chromosomes are translocated across the septum into the forespore.  
In stage III, a phagocytosis like process occurs where the mother cell engulfs the 
forespore. The septal peptidoglycan starts to degrade from the center to the 
periphery. The rigid structure in between the cells start to dissolve resulting in a 
bulging of the forespore into the mother cell, leading to the migration of 
membrane from the edges to the forespore, forming a double membrane with 
opposite polarity. σF and σE controls the whole process.  
The formation of the spore cortex occurs in Stage IV. Once the septum is 
formed σF transcribes σG in the forespore and σE transcribes σK in the mother cell. 
σG is activated in the engulfed forespore. σF and σG in the forespore govern the σE 
and σK of the mother cell. σE generates signals that help for the synthesis of σG in 
the forespore and its activation. σG and σK are involved in the formation of cortex 
and coat layers in the mother cell to encase the forespore.  
	  6	  
Coat formation and maturation of the spore occurs in Stage V and VI. The 
inner spore coat protein deposition occurs in the stage V and outer spore coat 
protein deposition in the stage VI. The inner spore coat is multilayered and 
complex. Once the formation of spore coat is completed, the spore develops 
resistance to chemicals and adverse conditions. The spore finally matures in Stage 
VI and is released from the mother cell. 
 
I.C Role of Sigma factors in Sporulation: 
The transcription of the genes, to form products that are responsible for the 
morphological changes in sporulation is controlled by the σ factors in the RNA 
polymerase. This occurs via a complex regulatory network.8 The Spo0A~P is 
important in the regulation. When higher levels of Spo0A~P is accumulated, σA 
that is present in higher amounts in the cell and σH present in minor amounts are 
activated. These help for the partition of the chromosomes to the mother and 
forespore and also the septum formation. σH RNAP transcribes the genes for σF 
and σA for σE. Only after the formation of the septum, the σF is active in the 
forespore and σE in the mother cell. The products of both these genes are used for 
the engulfment process where the forespore with opposite polarity in the 
membrane is formed. The σF is held inactive by the anti-σ factor SpoIIAB. This 
inhibition is reversed by anti-anti-σ factor SpoIIAA, as it binds to the SpoIIAB-
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σF and releases the σF by steric displacement.9 The anti-anti-σ factor SpoIIAA is 
inactive in the phosphorylated state. This is inactivated by SpoIIAB and activated 
by SpoIIE by dephosphorylation. Thus the activation of σF and σG involves the 
release of anti-σ factor SpoIIAB. The pro-protein precursors have to be 
proteolytically processed to activate the sigma factors in the mother cells. σF and 
σG controls the pro-σE and pro-σK respectively. Once the σF is activated this 
causes the activation of σE. The SpoIIR signal from the forespore activates the 
pro-σE via the protease SpoIIGA. Both SpoIIGA and pro-σE are found to be 
expressed in the mother cell. SpoIIGA cleaves the N-terminal pro-sequence of 
the pro-σE activating it to σE in to the mother cell.10 
σF RNAP transcribes for σG and σE RNAP for σK. The products of SpoIIIA 
and SpoIIIJ in the prespore are involved in the activation of σG. σG turns out to be 
active in the forespore that is engulfed. Transcription of the genes that cause the 
protein to condense are activated and also the chromosome is protected here so 
that the spore can be germinated when there are enough nutrients. σK is active in 
the mother cell. σE and σK are needed for the formation of the cortex and coat 
layers in the mother cell to surround the forespore. This σK also directs the 
transcription of genes that help for the lysis of the mother cell and mature spore. 
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Figure 3: Sigma factors at different stages of Sporulation 
 
 
 
I.D The Mother cell Metabolic Gene (mmg) Operon: 
The σE dependent promoters were screened to identify the genes involved 
in the intermediate stages of sporulation. It was found that one of these promoters 
controlled at least 5 open reading frames (ORF). These ORFs were named mmgA 
(393a.a), mmgB (287a.a), mmgC (379a.a), mmgD (371a.a), and mmgE. Later, the 
complete genome sequence revealed that a 6th ORF, yqiQ, was found. The 
products of the first three ORF were similar by sequence to the enzymes involved 
in the fatty acid metabolism and that of the fourth ORF is similar to citrate 
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synthase. The mother cell sigma factor σE is involved in the transcription of these 
genes and hence the name mmg (mother cell metabolic genes) operon.  
 
I.D.1 Transcriptional regulation: 
A 14 base pair sequence mmgO, which is located 22 bps downstream of the 
transcriptional start site of the mmg operon, is found similar to catabolite 
responsive elements (CRE) in other promoter regions. CcpA protein when bound 
to CRE in the presence of glucose, causes a decrease in transcription from 
specific promoters. It was shown that the mmgO and CcpA are needed for the 
glucose repression of mmg promoter activity in the σE -dependent promoters like 
mmg promoter. Thus the mmg operon is activated by σE but can be repressed by 
glucose. 
 
 
  
 
Figure 4: The Mother Cell Metabolic Gene (mmg) Operon.11 
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I.D.2 Functions of different genes: 
The mmgA gene product has 68% similarity and 49% identity to acetyl 
coenzyme A acetyl transferase (thiolase). That of mmgB has 55% identity and 
66% similarity to 3-hydroxybutyryl-CoA dehydrogenase9 and the product of 
mmgC is 52% identical and 68% similar to acyl-CoA dehydrogenase. The citrate 
synthase of Bacillus coagulans is 80% similar and 66% identical to that of the 
mmgD product. The sequence of mmgE is found to be similar to 2-methylcitrate 
dehydratase, and yqiQ to isocitrate lyase. 9,13 This shows that the genes mmgABC 
are homologs of thiolase, 3-hydroxyacyl CoA dehydrogenase and acyl CoA 
dehydrogenase respectively i.e. they are similar to the enzymes in the fatty acid 
metabolism.  
Based on sequence homology, mmgD, mmgE and yqiQ are similar to the 
enzymes involved in propionate metabolism The mmgDE and yqiQ functions as 
the enzymes in methyl citrate cycle, where propionyl-CoA is involved. One of 
the important regulators of the Kreb’s cycle is citrate synthase.  
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I.D.3 Proposed reactions for different genes:  
 
 
 
 
Figure 5: Proposed reactions of the genes mmgA, B and C 
 
 
 
In the citric acid cycle, citrate synthase catalyses the reaction, involving 
acetyl CoA and oxaloacetate with citrate as the product. In the methyl-citric acid 
cycle, propionyl CoA and oxaloacetate are involved resulting in methyl citrate as 
the product. It was found that mmgD-like enzymes in Pseudomonas aeruginosa 
and Salmonella typhimurium are bi-functional.12   
	  12	  
 
Figure 6: Condensation of Oxaloacetate and Acetyl-CoA to Yield Citrate;  
Condensation of Oxaloacetate and Propionyl-CoA to yield Methyl citrate  
 
 
 
I.D.3.A Putative pathway suggested for Bacillus subtilis13 
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I.E Fatty acid metabolism:  
In bacteria, phospholipids are the most commonly occurring class of lipids 
forming the major constituent of the cell membranes.14 Phospholipids contain a 
diacylglycerol, a phosphate group and a simple organic molecule like choline. 
Two hydroxy groups of  glycerol are linked to fatty acids via esters, whereas the 
third hydroxy group is linked to a phosphate ester. Hence the properties of the 
phospholipid depend on the distribution of fatty acids in the C1 and C2 positions 
and the nature of the phosphate derivative in the 3rd position. 
 Lysylphosphatidylglycerol are synthesized in high amounts in B.subtilis. 
The fatty acid components adjust the fluidity of phospholipid bilayer. The fatty 
acids involved in the lipid synthesis are divided into 2 categories; Saturated and 
Unsaturated fatty acids. B. subtilis has no poly-unsaturated fatty acids. 
Saturated fatty acids are divided into straight and branched chain fatty 
acids. Palmitic, stearic, linoleic and linolenic acids are the common straight 
carbon chain fatty acids in higher plants and animals and less common in 
Bacillus. The fatty acids in plants and animals are mostly polyunsaturated but the 
ones in bacteria are mostly branched, hydroxylated and rarely poly-unsaturated.  
In Bacillus subtilis, the terminally branched fatty acids like 13-methyl 
tetradeconic acid (iso- C15) and 15-methyl hexadeconic acids (iso- C17),  
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14-methyl pentadeconic acid (iso-C16) and in species of Sarcina the 12-
methyltetradeconic acids (anteiso-C15) were seen . The branched chain fatty acids 
are further divided into even numbered iso, odd numbered iso and anteiso 
depending on their biosynthetic origins. The iso and anteiso constitute about 55-
95% of the total fatty acids in B.subtilis. The anteiso-C15 is more abundant. Iso-
Methyl branched fatty acids have the branch point on the ω-2 carbon 
(penultimate carbon), while anteiso-methyl-branched fatty acids have the branch 
point on the ω-3 carbon (ante-penultimate carbon atom).  
The de novo synthesis of fatty acids, in most of the organisms, occurs by 
the repeated condensation of malonyl-coenzyme A with acetyl-CoA in the 
presence of the palmitic acid synthetases. The end product is palmitic acid and 
NADP is oxidized.  
 
Acetyl-CoA +7 malonyl- CoA +14 NADPH+14H+--------->  
                                            Palmitic acid + 7 CO2 + 14 NADP+   
 
But in Bacillus subtilis, the acyl Co-A esters like isobutyryl, isovaleryl or 
2-methylbutyryl are the chain initiators; malonyl-CoA act as the chain extenders 
and NADPH is the hydrogen donor.  
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Isobutyryl-CoA + 6 Malonyl Co-A + 12 NADPH + 12 -- 
          Iso-C16 acid + 6CO2 +12 NADP+   
 
I.E.1 β-Oxidation of fatty acids: 
Two carbon units are sequentially removed by the oxidative degradation of 
saturated fatty acids from the molecule in each turn of the cycle to form acetyl 
CoA, which enters the citric acid cycle. The β oxidation occurs initially by 
activation of the fatty acids by coenzyme A to form a fatty acyl thioester, which 
is followed by four repetitive steps, dehydrogenation, hydration, oxidation and 
thiolysis. 
Each round of the cycle results in the formation of acetyl-CoA 
and an acyl-CoA, which is 2 carbons shorter than the starting acyl CoA. The cycle 
is repeated  until the entire molecule is completely degraded into acetyl CoA 
products.  
Dehydrogenation: 
 The β oxidation initiates when two hydrogens are removed from the C-2 and C-3 
by acyl-CoA dehydrogenase to yield an α,β unsaturated acyl CoA. An enoyl CoA 
is formed which transfers the electrons to FAD, which is reduced to FADH2.  
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Hydration: 
The α,β unsaturated acyl CoA reacts with water in this step. The water acts as a 
nucleophile, which adds to the β carbon of the double bond forming an 
intermediate thioester enolate. In the presence of the enzyme enoyl-CoA 
hydratase, 3- hydroxyacyl Co-A is formed.  
Alcohol Oxidation: 
The 3- hydroxyacyl Co-A is oxidized to β keto acyl Co-A. This reaction is 
catalyzed by 3- hydroxyacyl Co-A dehydrogenase. This reaction needs NAD+, 
which is reduced to NADH/H+ as the by-product.  
Chain cleavage/ Thiolysis: 
This reaction is catalyzed by βketoacylCoAThiolase. This reaction takes place 
initially by the nucleophilic addition of the Cys-SH on the enzyme reacting with 
the keto group of β keto acyl-CoA followed by the cleavage of the C2-C3 bond 
resulting in an acetyl CoA enolate ion. This is protonated giving acetyl CoA. The 
attached acyl CoA undergoes nucleophilic acyl substitution with Coenzyme A 
resulting in acyl CoA. This enters another round of β oxidation for further 
degradation.  
If the starting fatty acid had an even number of carbons for example four 
carbons, at the end of the first round of β oxidation 2 acetyl-CoA. Molecules are 
found. If there are more carbons than four the reaction continues until the whole 
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molecule is converted to acetyl CoA. Similar is the case with the fatty acid 
having odd number of carbons in the chain, which would result in several acetyl 
Co-A but also one propionyl Co-A.  
 
 
 
 
 Figure 7: β-Oxidation of Fatty acids15 
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I.E.2 Fatty acid degradation enzyme complex 
 
In E.coli, five enzymes are involved in the long chain fatty acid β- 
Oxidation pathway.  They are acylCoA synthetases, acyl CoA dehydrogenase, 
enoyl CoA hydratase, 3-hydroxy acyl dehydrogenase and keto acyl-CoA 
thiolase16, 17 
These enzymes are also involved in the long chain fatty acid degradation in 
E.coli but the short chain Fatty acid catabolism requires three enzymes, crotonase, 
3-hydroxyacylCoA dehydrogenase and acyl CoA thiolase.16 The catabolism of β 
keto short chain fatty acids requires 2 more enzymes, acetyl CoA transferase and 
acetoacetylCoA thiolase. In E.coli, acetoacetylCoA thiolase and β ketoacylCoA 
thiolase were heat resistant. The molecular mass of acetoacetyl CoA thiolase in 
SDS-PAGE was 41,500 Da.  
It is known that the enzymes exist as a multi enzyme complex in E.coli 
with a molecular weight of 260, 000 Da. When analyzed by SDS PAGE, two types 
of subunits with the molecular weights 78 kDa and 42 kDa were seen by Schulz 
and co workers. The purified complex of fatty acid oxidation in E.coli was found 
to have the 3- hydroxyacyl-coenzyme A epimerase and enoyl CoA isomerase in 
addition to the enoyl CoA hydratase, 3-hydroxy acyl Co A dehydrogenase and 3-
keto acyl CoA thiolase activities.18.19 The genes that code for these enzymes form 
an fad operon. All these three enzymes co-purified as a result of heat treatment.  
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These proteins co-eluted from Sepharose 6B gel filtration column, which 
shows that they associate as a single multi protein complex. However, the acyl 
CoA synthetases and acyl CoA dehydrogenase were not seen in the complex after 
heat treatment.  
In E.coli, the fatty acid β-oxidation pathway is encoded by the fad (fatty 
acid degradation) regulon.20 A tetrameric complex containing 2 copies of FadB 
and FadA catalyses the other steps in β oxidation. FadB has the enoyl CoA 
hydratase and 3 –hydroxy acyl CoA dehydrogenase activity, whereas FadA has 3-
keto acyl CoA thiolase activity. 
The activities of all these complexes were tested with the appropriate 
substrates. The advantages of the β-Oxidation enzymes existing as a complex is 
the greater kinetic efficiency due to the channeling of Fatty acid oxidation 
intermediates from one active site to the next without equilibrating the medium 
and also to prevent accumulation of intermediates.  
Similar complexes were also seen in other organisms like  
Pseudomonas fragi21and, Caulobacter crescentus.20 
In Pseudomonas fragi, the complex exhibited enoyl-CoA hydratase, 3-
hydroxyacyl-CoA dehydrogenase, 3-oxoacyl-CoA thiolase, enoyl-CoA isomerase, 
and 3-hydroxy acyl-CoA epimerase.21 
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In Caulobacter crescentus, the complex exhibited acyl coenzyme A 
synthetases, acyl CoA dehydrogenase, enoyl CoA hydratase, 3-hydroxy acyl 
dehydrogenase and keto acyl-CoA thiolase.20 
The mmgA protein sequence in B.subtilis has 33% identity and 51% 
similarity to fadA of E.coli . Both mmgA and fadA have thiolase activity.  
mmgB protein sequence has 37% identity and 52% similarity to the fadB of 
E.coli. Both mmgB and fadB have 3-hydroxy acyl CoA dehydrogenase activity. 
Clustal W was used as a multiple sequence alignment computer program22, 
here, to identify the conserved sequence regions in mmgA and B of B.subtilis and 
FadA and FadB of E.coli.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
	  21	  
mmgA of B.subtilis with FadA of E.coli 
 
 
 
 
 
Figure 8: The multiple sequence alignment  of mmgA of B.subtilis with FadA of 
E.coli. In the figure , * refers to identical or  conserved residues in all sequences in 
the alignment, “:”  to conserved substitutions, “.”  Semi-conserved substitutions 
and  “-” indicates a gap inserted by the algorithm 
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mmgB of B.subtilis with FadB of E.coli 
 
 
 
 
 
Figure 9: The multiple sequence alignment  of mmgB of B.subtilis with FadB of 
E.coli. In the figure , * refers to identical or  conserved residues in all sequences in 
the alignment, “:”  to conserved substitutions, “.”  Semi-conserved substitutions 
and  “-” indicates a gap inserted by the algorithm. 
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I.F Methyl citric acid cycle : 
The acetyl Co-A  formed during the β oxidation pathway enter the citric 
acid cycle in combination with oxaloacetate forming citric acid, as shown below.  
 
Acetyl Co-A + Oxaloacetate + H2O  Citrate + CoA 
 
But when propionyl CoA is formed as a result of the β oxidation of odd number 
of carbon chains, it undergoes a different pathway called the methyl citric acid 
cycle where it combines with oxaloacetate forming methyl citrate.23,24 
 
Propionyl Co-A + Oxaloacetate + H2O  2 Methyl citrate + CoA 
 
Methyl citrate synthase, which also have the activity of citrate synthase, 
catalyses this reaction. The methyl citrate so produced isomerizes from cis-2- 
methylaconitase to methyl isocitrate followed by cleavage to pyruvate and 
succinate. Succinate is a citric acid cycle intermediate and is converted to 
oxaloacetate. Pyruvate can be converted to acetyl CoA. Thus the methyl citrate 
cycle catalyses the α oxidation of propionate to pyruvate.  
This whole pathway is found to involve 5 enzymes in E.coli .25 Of these 
only methyl citrate synthase and 2-methylisocitrate lyase are characterized. 
	  24	  
 
Figure 10: Methyl-Citrate Cycle :26 MCS- methyl citrate synthase, MCD- methyl 
citrate dehydratase, ACN- Aconitase, MCL- methyl isocitrate lyase, SDH- Succinate 
dehydrogenase, FUM- Fumarase, MQO, malate-quinone oxidoreductase. 
 
 
 
I.G. Overview Of The Previously Done Work 
 
Previously in our lab, work was done to determine the activities of the 
proteins encoded by the genes mmg ABCD. As shown in the table, MmgA11, 
MmgC27and MmgD28 were found to be active. However, our group has had 
difficulty in demonstrating the enzymatic activity of MmgB. MmgA, B, C and D 
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were cloned into a pET-28a vector separately, purified by Ni affinity 
chromatography and enzymatic activities were tested. There is an ongoing work in 
the lab on testing the enzymatic activity of yqiQ and also to establish a system for 
study of mmgE 
 
 
 
GENE CLONED PURIFIED DEMONSTARTED 
ACTIVITY 
mmgA YES YES YES11 
mmgB YES YES ?27 
mmgC YES YES YES27 
mmgD YES YES YES28 
mmgE NO NO NO 
yqiQ YES YES PARTLY29 
Table 1: Summary of the work done in Reddick’s lab 
 
 
 
A major problem we are approaching in this thesis is with mmgB. 
Russell Spencer encountered difficulty inconsistently observing the catalytic 
activity of MmgB towards D or L-β-hydroxybutyrl CoA.  
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We have stated a few hypotheses as to why our mmgB system provides 
inconsistent enzymatic activity.  
1) The presence of C-terminal histidine tag on the mmgB might be interfering 
with the activity.  
2) May be 3-hydroxybutyrylCoA is a wrong substrate 
3) Some of the fatty acid degradation enzymes are known to exist as a 
complex. Likewise, MmgB may also require such a complex to be fully 
functional. 
In this work we are beginning an approach to study the 3rd hypothesis. Towards 
this end we first need to test another hypothesis that Mmg proteins exist as a 
multisubunit complex. 
 
I.G.1 Goals for this research to test the hypothesis: 
 
1) To clone the mmgABCD gene into the pETDuet expression system for  co 
expression.  
2) To test whether or not the mmg fatty acid degradation enzymes form a multi 
subunit complex. 
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CHAPTER II 
 
OVER EXPRESSION AND PURIFICATION OF MMG PROTEIN 
COMPLEX FROM Bacillus subtilis 
II.A Introduction to Molecular Cloning 
Molecular cloning is a procedure where the gene of interest is isolated and 
amplified.  
1) Isolation of the gene of interest 
Isolation of the gene of interest is done by polymerase chain reaction.  
Initially primers are designed and a PCR reaction is conducted. After the 
successful PCR, the isolated gene is inserted into the host vector. Duet vectors 
pETDuet-1 and pACYCDuet are chosen for this work. The genes of interest were 
mmg A, B, C and D. The mmgA was isolated such that the gene will align with the 
sequence in the plasmid that codes for a C-terminal His-Tag. This allows us to 
purify the protein using a Nickel-Nitrilotriacetic Acid (Ni-NTA) column.  
2) Transformation 
The ligated product is transformed into a cloning strain of E.coli and the 
mixture is grown on agar plates with a selected antibiotic. Then the individual 
colonies are picked and screened for the plasmid of interest. 
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3) Screening 
Identifying the cells replicating the gene is important. This is done by DNA 
sequencing and PCR.  
 
II.A.1 pETDuet System 
The pET system is a commercially available system for cloning and 
expression of recombinant protein. The genes of interest are put under the control 
of bacteriophage T7 transcription and translation signals. When the T7 RNA 
polymerase is active and begins to work, all the cell resources are devoted to the 
translation of the desired gene.  
II.A.2 Duet Expression System 
All the Duet vectors have the T7 promoters for the expression of the target 
genes by IPTG induction. It is designed in such a way that 2 different target 
proteins can be co expressed in the E.coli. The vectors pETDuet-1 and pACYC 
Duet are used in my work. These two vectors can be replicated and co-expressed 
in the same host.  
pETDuet-1 has 2 Multiple Cloning Sites (MCS). In the beginning of each 
MCS, there is a T7 promoter/ lac operator and a ribosome-binding site (rbs). The 
plasmid also has pBR 322-derived ColE1 replicon, LacI gene and bla gene for 
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ampicillin resistance. pACYCDuet-1 vector has a similar arrangement but has the 
P15A replicon and cat gene for chloramphenicol resistance.  
The recombinant plasmid so produced is transferred to a host E.coli  strain 
BL21 (DE3), a strain that has the T7 RNA polymerase. “DE3” indicates that the 
host is a lysogen of λ bacteriophage DE3. The E.coli genome and the pETDuet 
plasmid have the lacI gene, which encodes the lac repressor protein. This protein 
prevents the binding of any RNA polymerase to the lac promoter region and hence 
the transcription of the T7 gene doesn’t occur. Once the IPTG is added, the lac 
repressor protein is removed, allowing the E.coli RNA polymerase to transcribe 
the T7 RNA polymerase. The T7 RNA polymerase transcribes the target gene in 
the plasmids in the promoter region, resulting in the production of protein. 
pETDuet-1 vector includes two multiple cloning sites (MCS). Each MCS 
has a T7 promoter, lac operator and ribosome-binding site for the expression of the 
target gene. The promoter is followed by the ribosome binding site and MCS. The 
presence of an optimized ribosome binding sequence on the mRNA aids in 
translation of a protein.  
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Figure 11: Over-expression System28 
 
 
 
II.A.3 Protein Purification:  
The purification of the His-tag protein.is done with nickel nitrilotriacetic acid  
(Ni-NTA) metal affinity chromatography. NTA is a tetradentate chelating 
absorbent. It has 6 ligand binding sites. Of which nickel was bound on the four-
ligand binding sites and a 6xHis tag occupies the remaining two. The His-tag 
securely holds the protein on to the metal chelating surface. 28 
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Figure 12: The interaction of the His-tag and Ni-NTA column28 
 
 
 
The protein as it moves down the Ni-NTA column, binds to the matrix. The 
column is rinsed with low concentration of imidazole to remove unwanted 
proteins in the wash step. The final elution buffer that is added has a high 
concentration of imidazole to elute the desired His-Tagged protein. Due to 
structural similarity, imidazole competes with the histidine of 6xHis tag protein 
and binds to the Ni-NTA on the column. 
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CHAPTER III 
 
RESULTS AND DISCUSSION 
III.A Amplification of mmgA and mmgB 
Mmg A and mmgB were successfully amplified from the Bacillus subtilis 
strain 168 genome by the polymerase chain reaction. In the agarose gel pictures, it 
can be seen that the amplified gene of mmgA falls between 1.0Kb and 1.2 Kb. This 
is consistent with the expected size of 1179bps.    
 
 
 
 
Figure 13: Agarose gel of the PCR reaction product of BS 168. 
Lane 1: Standards. Lane 2: negative control (without the template) of the PCR 
product. Lane 3: PCR product. The expected size of mmgA is 1179 bps  
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As shown in figure 12, the PCR product of mmgB is seen between 
0.7 kb and 0.8 kb and is consistent with its gene length 732bps. 
 
 
 
 
Figure 14: Agarose gel of the PCR of BS 168 genome. 
Lane 1: Standards. Lane 6: PCR product. The expected size of mmgB is 732 bps. 
 
 
 
III.A.1 Cloning mmgA into pETDuet-1 vector 
Restriction digestion and Ligation:  
MmgA and pETDuet-1 were cut with the restriction enzymes BamHI and SalI and 
purified on 1% agarose gel (Figure 13). Each bands was gel extracted and using 
T4-DNA ligase, mmgA was ligated into the vector. The ligation mixture was 
transformed into competent E. coli . Individual colonies were screened for the 
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presence of the plasmid with the insert by PCR. A plasmid that tested positive for 
the insert was transformed into DH5α, sent for sequencing and retransformed into 
E.coli BL21 (DE3). 
 
 
 
 
Figure 15: Agarose gel of the restriction digested plasmid and mmgA. Lane 1: 
Standards. Lane 3: Restriction digested plasmid Lane 5: Restriction digested 
insert. The length of the plasmid vector is 5420 bp and that of the insert mmgA is 
1179 bp. 
 
 
 
After ligation, individual colonies were picked up and screened for the 
plasmid that tested positive for the insert. Here, three individual colonies were 
picked up and tested. The sample that gave the brighter band (in figure 14, the one 
in the fourth lane) was selected for further retransformation and sequence 
submission.  
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Figure 16: Agarose gel showing the screened plasmid samples testing for the insert 
mmgA, by PCR. Lane 1: Standards. Lanes 2: positive control with BS168 genomic 
DNA. Lane 3: negative control. Lane 4, 5, 6: Positive Transformants. 
 
 
 
 
Figure 17: Agarose gel showing plasmid with the insert. 
Lane1: Standards. Lane2: Negative control of the PCR product. Lane 3: Plasmid 
with the insert. The expected length of the vector with the mmgA insert is 6599 bp.  
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III.A.2 Cloning mmgB into pETDuet-1 with mmgA 
 Next mmgB gene was inserted into this vector that already has the mmgA 
gene. To accomplish this, the first step was to cut both mmgB and pETDuet-
1/mmgA with the restriction enzymes NdeI and XhoI. Then they were purified by 
a 1% agarose gel. As shown in figures 16 and 17. Those bands were gel extracted 
and by using T4-DNA ligase  the mmgB gene was ligated into the vector. 
 
 
 
Figure 18: Agarose gel picture showing the insert after restriction digestion. 
Lane1: Standards Lane5: Insert after restriction digestion.  
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Figure 19: Agarose gel picture showing the restriction digested product of the 
pETDuet/mmgA. Lane1: Standards Lane 2: pETDuet-1/mmgA. Lane 4: amplified 
mmgB. The expected length of the plasmid with the insert mmgA is 6599 bp and 
mmgB is 732 bps 
 
 
 
The individual transformants obtained form a mixture screened for the 
presence of the plasmid with the insert by PCR. Five colonies were picked to test 
for the insert and all of them gave a positive result. The sample in the 3rd lane was 
transformed into DH5α, sent for sequencing and retransformed into E.coli BL21 
(DE3). 
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Figure 20: Agarose gel showing the screened plasmid samples testing for the insert 
mmgB using PCR. Lane1: Standards  
Lanes 2: positive control. Lane 8: negative control. Lanes 3, 4, 5, 6, 7: 
Transformants. 
 
 
III.B Amplification of mmgC and mmgD  
III.B.1 Cloning mmgC into pACYCDuet vector 
Restriction digestion and ligation 
MmgC and pACYCDuet were cut with the restriction enzymes PciI and 
NcoI and purified by 1% agarose gel as shown in the figure 19. Those bands were 
gel extracted, and using T4-DNA ligase, mmgC was ligated into the vector. 
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Figure 21: Agarose gel showing PCR product of mmgC and the plasmid 
pACYCDuet after restriction digestion.  
Lane 1: Standards. Lane 4: PCR product (insert) Lane 5: Plasmid after restriction 
digestion. Expected length of the PCR product mmgC is 1134 bp and that of 
pACYCDuet vector is 4008bps. 
 
 
 
Four individual colonies were selected and screened for the presence of the 
plasmid with the insert by PCR as shown in the figure 20. The sample in the 4th 
lane was taken and transformed into DH5α. 
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Figure 22: Agarose gel showing the screened plasmids of pACYCDuet for the 
insert by PCR. Lane1: Ladder Lanes 2: positive control Lane 3: negative control 
Lanes 4, 5, 6, 7: Transformants 
 
 
 
After transformation into E. coli we now have the pACYC vector with 
mmgC gene. This sample was sent for the DNA sequencing and retransformed into 
the E.coli BL21 (DE3). 
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Figure 23: Agarose gel showing the PCR product before sequencing. Lane 1: 
Standards. Lane 2 and 6: PCR product of the sample to be sequenced. The 
expected size of mmgC is 1134 bps. 
 
 
 
III.B.2 Cloning mmgD into pACYCDuet vector containing mmgC 
Restriction digestion and ligation 
We have the mmgC cloned into the vector pACYCDuet. The next step was 
to insert mmgD into the same vector containing mmgC. 
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Figure 24: Agarose gel showing the amplified PCR product of mmgD. 
 Lane 1: Ladder Lane 2: amplified PCR product. Lane 3: Negative control of the 
insert. The expected length of mmgD is 1116 bps. 
 
 
 
mmgD and pACYC were  cut with the restriction enzymes NdeI and XhoI 
and purified on a 1% agarose gel as shown in the figure 23. 
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Figure 25: Agarose gel showing the insert and plasmid after restriction digestion. 
Lane 1: Standards Lane 3, 4: the Insert  
Lanes 6 and 7: Plasmid. Expected length of the insert mmgD is 1116bp and that of 
the pACYCDuet/mmgC is 5142bps. 
 
 
 
The bands obtained from 1% agarose gel were gel extracted and ligated 
with T4-DNA ligase. Three individual colonies were picked up and screened for 
the presence of the plasmid that tested positive for the insert. All the three gave a 
positive result as shown in the figure 26.  
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Figure 26: Agarose gel showing the screened plasmid samples for mmgD. Lane1: 
Standards Lane 2: Positive control Lane 3: negative control Lanes: 4, 5, 6: 
Transformants. 
 
 
 
The colony in the 4th lane was taken as it gave the brightest band and 
transformed into BL21 (DE3). A single colony was picked and tested with PCR 
before sending it for sequencing. It is shown in the figure 27.  
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Figure 27: Agarose gel showing the PCR product before sequencing. Lane 1: 
Standards. Lanes 3, 4: mmgD PCR products. 
 
 
 
Gene 100 % Sequence 
alignment 
No .of base pairs in 
each gene 
   
pETDuet-mmg A Yes  1179 
pETDuet-mmg B Yes 732 
pACYCDeut-mmg C Yes 1134 
pACYCDuet-mmgD Yes 1116 
Table 2: The results of the DNA sequencing of each gene. 
 
 
 
III.C Mmg ABCD Purification:  
 MmgAB/pETDuet was transformed into BL21 (DE3). Then a culture of 
BL21(DE3) /mmgAB/pETDuet was made competent and transformed with 
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pACYCDuet/mmgCD. This resulted in a single strain of E. coli BL21 (DE3) 
containing both plasmids. 
After successful transformation into E.coli BL21 (DE3), the  
mmg ABCD  was over expressed in liquid culture. We incubated the induced 
culture overnight at 37 °C and 25 °C. At 37 °C, SDS-PAGE showed that large 
amounts of protein was produced but couldn’t be purified due to inclusion body 
formation. This was observed by running an SDS gel of the whole cell extract, 
which couldn’t give the appropriate protein band after purification. So in an effort 
to decrease the inclusion body formation and increase in the amount of protein 
production, overnight incubation was done at 18 °C.  
To solve this problem, we also tried inducing with lower concentrations, 
(0.05 mM, 0.2 mM, 1 mM) of IPTG. Samples were collected at different stages of 
the preparation of the protein sample. The expected molecular weights of mmgA 
with the His-Tag is 41,019 Da, mmgB is 26,919 Da, mmgC is 40,710 Da and that 
of mmgD is 41,946 Da. 
 
III.C.1. 10% SDS PAGE gel of BL21 (DE3) ABCD protein sample with 0.05 
mM IPTG  
The samples were collected at each stage in the preparation of the protein 
sample. In figure 28, a prominent band was seen at 26 KDa until the sample was 
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sonicated and centrifuged. After the centrifugation some of the bands were not 
observed. This could be because of the formation of inclusion bodies.. However, 
bands were seen around 40 KDa.  
 
Figure 28: 10% SDS PAGE gel of BL21 (DE3) ABCD protein sample with 0.05 
mM IPTG at 18 °C 
(From Right to left) Lane 9: Protein ladder Lane 8: after overnight growth with 
IPTG Lane 7: After centrifugation Lane 6: Supernatant Lane 5: After adding 
Lysozyme Lane 4: After sonication Lane 3: before syringe filter Lane 2:  crude 
extract. Lane 1: Column flow through of the crude extract. 
 
 
 
Figure 29 is a continuation of figure 28. The samples from the column with 
different buffers were collected and analyzed on the SDS gel. In figure 29, the 
bands were not clear in any of the samples. We concluded that 0.05 mM of IPTG 
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is not best for the preparation of protein sample. So, we tried a different 
concentration, 1 mM IPTG. 
 
 
 
Figure 29: 10% SDS PAGE gel of BL21 (DE3) ABCD protein sample with 0.05 
mM IPTG at 18 °C.(From Right to left) Lane 9: Protein Ladder. Lane 8: 5 mM 
imidazole. Lane 7: 60 mM imidazole. Lanes 3, 4, 5, 6: 1 M imidazole. 
 
 
 
III.C.2. 10% SDS PAGE gel of BL21 (DE3) ABCD protein sample with 1 mM 
IPTG  
As shown in figures 30, the crude extract had interacting proteins especially 
on the molecular weight range for mmg B. Those bands were not observed after 
the centrifugation step. In figure 31, the bands from the 1 M imidazole were not 
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clear, which could be because of the formation of inclusion bodies and being lost 
due to 1 mM IPTG.  
 
 
 
 
Figure 30: 10 % SDS PAGE gel of BL21(DE3) ABCD protein sample with 1 mM 
IPTG at 18 °C.(From Right to left) Lane 9: Protein ladder Lane 8: after overnight 
growth with IPTG Lane 7: After centrifugation Lane 6: Supernatant Lane 5: After 
adding lysozyme. Lane 4: After sonication Lane 3: before syringe filter. Lane 2:  
crude extract. Lane 1: Column flow through of the crude extract 
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Figure 31: 10% SDS PAGE gel of BL21 (DE3) ABCD protein sample with  
1 mM IPTG at 18 °C. 
(From Right to left) Lane 10: Protein Ladder. Lane 9: 5 mM imidazole. sample 
Lane 8: 60 mM imidazole. Lanes 4, 5, 6, 7:  
1 M imidazole. 
 
 
 
III.C.3. 10% SDS PAGE gel of BL21 (DE3) ABCD protein sample with 0.2 
mM IPTG  
 In figure 32, we see 26 kDa band in all the samples. Bands around 40 kDa 
were seen after sonication in the crude extract and in the column flow through of 
the crude extract.  
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Figure 32: 10% SDS PAGE gel of BL21 (DE3) mmg ABCD protein sample with 
0.2 mM IPTG at 18 °C 
(From Right to left) Lane 11: Protein ladder Lane 10: after overnight growth with 
IPTG. Lane 9: After centrifugation. Lane 8: Supernatant. Lane 7: After adding 
Lysozyme. Lane 6: After sonication but before centrifugation. Lane 5: before 
syringe filter. Lane 4:  crude extract. Lane 3: Column flow through from loading 
crude extract. 
 
 
 
In the figure 33, the column flow through of the 5 mM Imidazole and 
60mM imidazole, bands were seen at 26 kDa and also around 40 kDa. One of the 
bands that was seen with 5 mM imidazole disappeared with 60 mM IPTG. In the 
first and second ml of the 1 M imidazole, bands were seen at the 26kDa and also 
40kDa. 
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Figure 33: 10% SDS PAGE gel of BL21 (DE3) ABCD protein sample with 0.2 
mM IPTG at 18 °C.(From Right to left) Lane 9: Protein Ladder Lane 8: 5mM 
imidazole Lane 7: 60 mM imidazole Lanes 3, 4, 5, 6: 1mM imidazole. 
 
 
 
0.2 mM IPTG was used in the further experiments as it gave good and consistent 
results when compared to that of 0.05 mM and 1 M IPTG.  
 
III.C.4. 10% SDS PAGE gel of BL21 (DE3) AB protein sample with 0.2 mM 
IPTG  
In figure 34, it can be seen that the sample with only AB was run on the 
SDS gel. In the lane 8 we observed a band around 40 kDa. And also in figure 35 
we observed faint bands around 40 kDa, with 1 M imidazole samples.  
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Figure 34: 10% SDS PAGE gel of BL21 (DE3) AB protein sample with 
0.2 mM IPTG at 18 °C. Lane 1: Ladder. Lane 2: After overnight growth with 
IPTG. Lane3: Supernatant after centrifugation. Lane 4: Before adding Lysozyme. 
Lane 5: After adding Lysozyme. Lane 6: After sonication.  
Lane 7: Crude extract before column flow through. Lane 8: Column flow through 
of crude extract. Lane 9: 5 mM imidazole. 
 
 
 
 
Figure 35: 10% SDS PAGE gel of BL21(DE3) AB protein sample with 0.2mM 
IPTG and at 18 °C. Lane 1: Ladder. Lane 2: 60 mM imidazole, Lane 3, 4, 5, 6: 
 1 M imidazole  
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III.C.5. 10% SDS PAGE gel of BL21 (DE3) CD protein sample with 0.2 mM 
IPTG  
In figure 34, we see the gel containing the protein sample of only mmg CD. 
We were able to observe bands in the crude extract after running through the 
column. Protein bands were not seen in the lanes containing 5 mM , 60 mM. A 
band around 25 kDa was seen in the 4th ml of the eluent ie; 1 M imidazole. 
 
Figure 36: 10% SDS PAGE gel of BL21(DE3) CD protein sample with 0.2mM 
IPTG and at 18 °C. Lane 1: Ladder. Lane 2:Column flow through of the Crude 
extract. Lane 3: 5 mM imidazole. Lane4: 60 mM imidazole. Lanes 5, 6, 7, 8, 9: 1 
M imidazole  
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III.C.6 10% SDS PAGE GEL WITH BL21 (DE3) ABCD protein sample with 
0.2mM IPTG . 
Figure 37 shows the gel with bands of the BL21 (DE3) ABCD protein 
sample. We were able to see bands at 26 KDa and around 40 KDa in the crude 
extract and also the column flow through of the crude extract. The sample from 
the 1 M imidazole was not clearly seen but a faint band was seen around 40 KDa. 
           
Figure 37: 10% SDS PAGE gel showing the BL21 (DE3) ABCD protein 
sample with 0.2mM IPTG and at 18 °C. Lane1: Protein Ladder Lane2: crude 
extract Lane 3: Column flow through of the crude extract Lane 4: Binding 
buffer. Lane 5: Wash buffer Lanes 6, 7, 8, 9: Eluent buffer. 
 
 
 
Since we weren’t able to clearly see the bands of the protein in the Eluent 
column flow through of BL21 (DE3) ABCD, the eluents of BL21 (DE3) AB, 
BL21 (CD), and BL21 (DE3) ABCD were concentrated using Centricon® Plus-20 
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Centrifugal Filter devices. These samples were analyzed on the 10 % SDS-PAGE 
gel as shown in the figure 38. 
 
 
  
Figure 38: 10% SDS PAGE gel showing the concentrated Eluent column 
flow through of BL21 (DE3) ABCD protein sample. Lane 1: protein Ladder 
Lane 3: Eluent of BL21 (DE3) CD protein sample, Lane 5: Eluent of BL21 
(DE3) AB protein sample, Lane 7: Eluent of BL21 (De3) ABCD   
 
 
 
 In Figure 38, lane 3 has the BL21 (DE3) CD sample. We observed a band 
around 25 kDa, which we should not have seen since none of the proteins in the 
sample has a His-tag. Thos opens a point for future research. The lane 5 has the 
BL21 (DE3) AB sample. We observed a band around 25 kDa which is suggestive 
of MmgB, but we did not observe a band consistent with MmgA, although we did 
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observe a fuzzy band around 40 kDa. At this point we were expecting to see a 
clear band ~ 40 kDa because MmgA has a His-tag. Lane 7 has the BL21 (DE3) 
ABCD sample. We see a band at ~ 26 kDa which is suggestive of MmgB. We also 
observed a band around 40 kDa which could be MmgA or MmgC. We also 
observed a band at ~ 80 kDa. This protein likely originated from E.coli. MmgA is 
a close homolog of FadA. FadA is known to form a complex with FadB. Therefore 
it is possible that MmgA can likewise form a complex with FadB. Since MmgA 
has a His-tag, there are chances that the FadB protein from E.coli may have 
coeluted with MmgA. 
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CHAPTER IV 
EXPERIMENTAL SECTION 
IV.A Experimental Details:  
IV.A.1: Cloning the mmgABCD genes. 
Genomic DNA from Bacillus subtilis strain 168 (BS168) was isolated using 
the Wizard®Gemomic DNA purification kit. This served as a template for the 
polymerase chain reaction experiments. Primers were designed to amplify the 
gene of interest. 10 µl of Phusion 5xHF buffer, 1 µl of 10mMdNTPs, 2 µl of the 
extracted BS168, 0.5 µl of Phusion polymerase and 1.25 µl each of upstream and 
downstream primers were used.  
The thermo cycler was set up as 1X cycle of 98.0 ºC for 1 min as the 
incubation temperature, followed by the 25X cycle primer extension temperatures 
of 98.0 ºC for 0.05 mins as the denaturation temperature, 45ºC - 70ºC for 30 secs 
to 1 min as the annealing temperature, 72 ºC for 30 sec to 1 min as the extension 
temperature for 30 cycles and 1x cycle of 72 ºC for 10 mins and was held at 
4ºC. The annealing temperature depends on the Tm if the primers.  
The PCR was setup for each gene with a difference in the annealing 
temperatures depending on the lowest Tm among the upstream and downstream 
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primers. The annealing temperature was 62 ºC for mmgA and mmgD and 63ºC for 
mmgB and mmgC 
Primers: 
mmgA:  
• Upstream:     5' GAG GGG ATC CCA TGA GGA AAA CAG T 3'  
BamHI -- restriction site enzyme.  
Tm – 60.7 °C 
• Downstream:  5'CAT GTC GAC ATG AAC CTG CAC TAA GA 3'  
Sal I -- restriction site enzyme. 
Tm – 59.3 °C 
mmgB: 
• Upstream:     5' CGG AGC ATA TGT TGA AAC GGC TGA AG 3'  
XhoI -- restriction site enzyme.  
Tm – 60.0 °C 
• Downstream: 5' AAA CTC GAG TCA GGA AGT CTT CTC CT 3'  
NdeI -- restriction site enzyme. 
Tm – 60.2 °C 
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mmgC: 
• Upstream:      5'GCG GAC ATG TAT GTA ACC CAA GAG C 3'  
PciI -- restriction site enzyme. 
Tm – 59.7 °C 
• Downstream:  5' TTT TGT AAG CTT GGT TCC GCC AAG C 3’  
NcoI -- restriction site enzyme. 
Tm – 60.5 °C 
mmgD: 
• Upstream:     5' GTT GAG CAT ATG GAG GAG AAA CAG CA 3'  
XhoI -- restriction site enzyme. 
Tm – 59.1°C 
• Downstream:  5' TAC CAG CTC GAG TCA TGA TTT TGT TT 3'  
NdeI -- restriction site enzyme.  
Tm – 59.8 °C 
The PCR products were purified using QiaQuick® PCR Purification kit. 
The PCR reactions were analyzed by 1% Agarose gel electrophoresis with 
ethidium bromide.  
The desired restriction enzymes were added to both the target plasmid and 
PCR products. 1% Agarose gel was run to verify the products after the restriction 
digestion. Then the desired fragments were extracted from the gel using 
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QIAquick Gel Extraction Kit and ligated using T4 DNA ligase, into the multiple 
cloning site of pETDuet, in a thermo cycler. The ligation temperatures were 37 ºC 
for 30 mins, 23 ºC for 2 hr 30 mins and held at 16 ºC overnight.  
The gene mmgA was cloned into the pETDuet vector. Then resultant 
ligated product was transformed into DH5α E.coli competent cells and plated on 
LB agar containing ampicillin (50mg/ml). Individual colonies were picked and 
grown in LB medium containing ampicillin. Plasmids from each culture were 
tested for insert by PCR using the cloning primers followed by 1 % Agarose gel 
electrophoresis. Plasmids that tested position for desired insert was retransformed 
into BL21 (DE3) strain and plated on the LB agar plate containing ampicillin. A 
colony was picked and grown in LB broth with ampicillin; plasmid purified and 
sent for sequencing. Also another colony was grown in LB containing ampicillin 
and stored at -80 °C in 10% glycerol. 
The same procedure was followed to clone mmgB into the pETDuet vector 
containing mmgA (pETDuet/mmgA). Similarly mmgC was cloned in to the 
pACYC vector followed by mmgD into pACYC/mmgC vector, but 
chloramphenicol was used instead of ampicillin. 
The resultant plasmid products are pETDuet-mmgAB and pACYCDuet-
mmgCD. 
All the four genes A, B, C, D (Duet system) are to be expressed in a single 
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host. To accomplish that, the BL21 (DE3)/pETDuet-mmgAB was streaked on to 
an LB plate containing ampicillin. A single colony was picked and grown on LB 
for 4-5 hrs. Centrifuged for 5 minutes at maximum speed. The supernatant was 
discarded and the pellet was dissolved in 3 ml of 50mM CaCl2 and incubated on 
ice for 30 minutes. The culture was centrifuged and the pellet was redissolved in 1 
ml of 50mM CaCl2. For the transformation, 1-2 µl of pACYCDuet-mmgCD was 
added to 50 µl of competent cells. Incubated on ice for 30 mins followed by 
incubation at 37 °C for 2 mins and incubated at room temperature for 10 mins. 
One ml of LB was added and incubated at 37 °C for 1-2 hours. Then the cells are 
centrifuged at 8000 rpm for 3-5 mins, 1ml of the supernatant was discarded, and 
the cell pellet was resuspended in the remaining supernatant. Twenty  µl of these 
cells were plated on the LB plates, containing both the antibiotics, 
chloramphenicol and ampicillin, and incubated at 37 °C overnight. Individual 
colonies of this strain BL21 (DE3)/pETDuet-mmgAB/pACYCDuet-mmgCD were 
picked for further cultures. 
 
IV.A.2 Purifying the complex:  
One colony (BL21 (DE3/pETDuet-mmgAB/pACYCDuet-mmgCD) was 
inoculated into 5 ml LB containing 1µl of both the antibiotics, chloramphenicol 
(34mg/ml) and ampicillin (50mg/ml). The following day 2 ml of this starter 
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culture was inoculated into the 1liter LB containing ampicillin and 
chloramphenicol and allowed to grow at 37 °C. Samples were taken every 20 mins 
after 3-4 hrs and measured the absorbance until the optical density at 595 nm was 
0.5-0.6. At this point Isopropyl-ß-D-thiogalactopyranoside (IPTG) (final 
concentration of 1mM) was added and the culture was kept in the shaker at 18 °C 
overnight.  
 The cells from the overnight culture was centrifuged, the following day, at 
6000 rpm for 30 mins at 4 °C. The pellet was washed with the 20ml of binding 
buffer (4M sodium chloride, 160 mM Tris, 40 mM imidazole) pH 7.9 and mixed 
with the magnetic stirrer and was transferred into a beaker and kept on ice. 
Lysozyme was be added and stirred for 15 mins and sonicated for 3 mins and the 
centrifuged at 11000 rpm for 30 mins at 4 °C. The resultant solution was filtered 
using a Corning ® 0.45 micron, 26mm syringe.  
 After lysing the cells, the resultant solution was passed through a Ni-NTA 
column. We slowly increased the concentration of imidazole to remove the 
undesired proteins and to finally elute the mmgA along with the associated 
proteins with high concentration of imidazole. 
 We analyzed this elution mixture by SDS-PAGE. If the mmg proteins do 
not form a complex, then we expect to see only one band in the gel of the His-
tagged mmgA (41019Da). If they form a complex, then we expect to see 
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additional bands matching the molecular weights of the other proteins (mmgB - 
26919.2 Da, mmgC – 40710.9Da and mmgD – 41946.6 Da). 
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CHAPTER V 
 
CONCLUSIONS AND FUTURE WORK 
MmgAB were successfully cloned into pETDuet-1 and mmgCD were also 
cloned pACYCDuet-1. This was confirmed from by DNA sequencing data. All 
these plasmids were established in E.coli strain BL21 (DE3), to give a single 
strain, which can coexpress all four genes.  
The transcription and translation was induced by the addition of IPTG to 
the culture. Because of the presence of an N-terminal His-tag on mmgA, a Ni-NTA 
column was used to purify the protein sample. After trying different 
concentrations of IPTG, 0.2 mM was found to be the best concentration for our 
experiments, as protein bands were seen clearly and consistently by SDS-PAGE 
when this concentration was used. 
We were able to observe proteins with apparent molecular weights of 26 
KDa and ~40 kDa, in the Elution buffer from cultures expressing all the genes. 
This suggests that mmgB may be interacting at least with MmgA. 
In addition to the 26 kDa band (which may be MmgB), protein was also 
detectable in the 40-50 kDa range. Due to the low resolution of SDS-PAGE it is 
unclear whether this protein was comprised of only MmgA or additional proteins 
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with similar molecular weights (MmgC - 40710 Da, and MmgD- 41946 Da). At 
this stage, however, these results are suggestive that the mmg fatty acid 
degradative pathway enzymes indeed interact in a complex. 
We will explore the composition of this protein mixture by MALDI-MS 
experiments that can also offer sequence data.  
The experiments also reveal the identity of the ~80 kDa protein coeluting 
with the potential mmg complex. It is possible this ~80 kDa is the E. coli fatty acid 
metabolism enzyme. In the next steps, the identity of this protein in the coeluting 
with the complex is to be confirmed and measure the activity of the complex. 
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